Quail Aleksei Aleksandrovich

Quail Aleksei Aleksandrovich

Biography

2024: Appointment as CEO of Rosatom Health Technologies

In October 2024, Alexey Perepelitsa was appointed new General Director of Rosatom Health Technologies JSC (RTZ JSC, formerly Rusatom Healthcare JSC). In this position, he replaced Igor Obrubov. This is evidenced by the data of the Kontur. Focus service, which Zdrav.Expert got acquainted with.

Before heading RTZ, Alexey Perepelitsa worked in the company as Deputy General Director for Construction and Technical Affairs. This was reported on the company's website.

Under the leadership of Obrubov, RTZ signed a special investment contract (SPIC) for the construction of Europe's largest production of radiopharmaceuticals (FPM) in the science city of Obninsk. The plant will be erected to GMP (Good Manufacturing Practice) standards. The volume of investments in the project is estimated at 12 billion rubles, the capacity of the site is 89 thousand curies. In addition, RTZ was included in a number of import substitution projects for critical medical equipment, including the flagship developments of domestic high-voltage magnetic resonance tomographs of 1.5 T. The volume of investments in the project was not disclosed, earlier experts estimated the cost of similar projects at 4.5 billion rubles.

Rosatom Health Technologies is part of the state corporation Rosatom and is engaged in the development of various projects in the field of health care and nuclear medicine. The division includes specialized organizations and enterprises of the state corporation with developments in the field of nuclear medicine, the production of radioisotope products, equipment for radiation sterilization and creating complex solutions for turnkey medicine^[1]

Notes